Cargando…

Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy

BACKGROUND: Previous studies have found that patients with subclinical interstitial lung disease (ILD) are highly susceptible to developing radiation pneumonitis (RP) after thoracic radiation therapy. In the present study we aimed to evaluate the incidence of and risk factors for RP after thoracic i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fangjuan, Liu, Hui, Wu, Hongyu, Liang, Shixiong, Xu, Yaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045204/ https://www.ncbi.nlm.nih.gov/pubmed/33849579 http://dx.doi.org/10.1186/s13014-021-01798-2

Ejemplares similares

Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy
por: Li, Fangjuan, et al.
Publicado: (2018)

Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy
por: Zhou, Ziyang, et al.
Publicado: (2017)

Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis
por: Lee, Yun Hee, et al.
Publicado: (2015)

Genetic variants of SP‐D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy
por: Xu, Li, et al.
Publicado: (2019)

Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011)

Decreased risk of radiation pneumonitis with concurrent use of renin-angiotensin system inhibitors in thoracic radiation therapy of lung cancer
por: Zheng, Yawen, et al.
Publicado: (2023)

Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer
por: Tatsuno, Saori, et al.
Publicado: (2022)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy
por: Noda‐Narita, Shoko, et al.
Publicado: (2022)

The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation
por: Ren, Chengbo, et al.
Publicado: (2018)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022)

Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer
por: Kong, Moonkyoo, et al.
Publicado: (2019)

High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis
por: Szejniuk, Weronika Maria, et al.
Publicado: (2021)

Pretreatment Factors Influencing Radiation Pneumonitis after Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
por: Harris, Alexander A, et al.
Publicado: (2020)

Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer
por: Ozawa, Yuichi, et al.
Publicado: (2015)

Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies
por: Lu, Chi, et al.
Publicado: (2018)

Interstitial pneumonitis in a castration-resistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: a case report
por: Yanai, Yoshinori, et al.
Publicado: (2019)

Bilateral diffuse grade 5 radiation pneumonitis after intensity modulated radiation therapy for localized lung cancer
por: Osborn, Virginia W, et al.
Publicado: (2017)

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
por: Kashihara, Tairo, et al.
Publicado: (2020)

Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
por: Yamashita, Hideomi, et al.
Publicado: (2007)

Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Impact of genetic variant of HIPK2 on the risk of severe radiation pneumonitis in lung cancer patients treated with radiation therapy
por: Tang, Yang, et al.
Publicado: (2020)

Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer
por: Inoo, Hiroyuki, et al.
Publicado: (2022)

The Risk Factors for Radiation Pneumonitis after Single-Fraction Carbon-Ion Radiotherapy for Lung Cancer or Metastasis
por: Ono, Takashi, et al.
Publicado: (2021)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design
por: Moiseenko, Vitali, et al.
Publicado: (2020)

Predictive Factors for Radiation Pneumonitis in Lung Cancer Treated with Helical Tomotherapy
por: Kim, Youngkyong, et al.
Publicado: (2013)

Association of DNA repair gene polymorphisms with the risk of radiation pneumonitis in lung cancer patients
por: Du, Lehui, et al.
Publicado: (2017)

Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients
por: Meng, Yinnan, et al.
Publicado: (2019)

Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient
por: Hosono, Yuki, et al.
Publicado: (2017)

Curcumin Mitigates Radiation-induced Lung Pneumonitis and Fibrosis in Rats
por: Amini, Paiman, et al.
Publicado: (2018)

The role of procalcitonin in differential diagnosis between acute radiation pneumonitis and bacterial pneumonia in lung cancer patients receiving thoracic radiotherapy
por: Wang, Zhiwu, et al.
Publicado: (2020)

Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
por: Kim, Kyeong-Hyun, et al.
Publicado: (2013)

A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation
por: Shi, Hua-shan, et al.
Publicado: (2012)

Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy
por: Jia, Wenxiao, et al.
Publicado: (2021)

The TGF-β1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients
por: Kim, Ji-Yoon, et al.
Publicado: (2009)

Lack of dose dependency for radiation pneumonitis after chemoradiotherapy with the use of tomotherapy for lung cancer
por: Masuoka, Yutaka, et al.
Publicado: (2022)

Adoption of Biologically Effective Dose of the Non-Target Lung Volume to Predict Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy With Variable Fractionations for Lung Cancer
por: Jiao, Yuxin, et al.
Publicado: (2020)

Parasitic infestation of lung: An unusual cause of interstitial pneumonitis
por: Shah, Parth, et al.
Publicado: (2016)

Osimertinib: Pneumonitis and interstitial lung disease: case report
Publicado: (2022)

Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer
por: Torresan, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mdu1juvas78ep30mjulg9kc3de